Cargando…

Electrolytic ablation enables cancer cell targeting through pH modulation

Minimally invasive ablation strategies enable locoregional treatment of tumors. One such strategy, electrolytic ablation, functions through the local delivery of direct current without thermal effects, facilitating enhanced precision. However, the clinical application of electrolytic ablation is lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Perkons, Nicholas R., Stein, Elliot J., Nwaezeapu, Chike, Wildenberg, Joseph C., Saleh, Kamiel, Itkin-Ofer, Roni, Ackerman, Daniel, Soulen, Michael C., Hunt, Stephen J., Nadolski, Gregory J., Gade, Terence P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123816/
https://www.ncbi.nlm.nih.gov/pubmed/30271931
http://dx.doi.org/10.1038/s42003-018-0047-1
_version_ 1783352911091204096
author Perkons, Nicholas R.
Stein, Elliot J.
Nwaezeapu, Chike
Wildenberg, Joseph C.
Saleh, Kamiel
Itkin-Ofer, Roni
Ackerman, Daniel
Soulen, Michael C.
Hunt, Stephen J.
Nadolski, Gregory J.
Gade, Terence P.
author_facet Perkons, Nicholas R.
Stein, Elliot J.
Nwaezeapu, Chike
Wildenberg, Joseph C.
Saleh, Kamiel
Itkin-Ofer, Roni
Ackerman, Daniel
Soulen, Michael C.
Hunt, Stephen J.
Nadolski, Gregory J.
Gade, Terence P.
author_sort Perkons, Nicholas R.
collection PubMed
description Minimally invasive ablation strategies enable locoregional treatment of tumors. One such strategy, electrolytic ablation, functions through the local delivery of direct current without thermal effects, facilitating enhanced precision. However, the clinical application of electrolytic ablation is limited by an incompletely characterized mechanism of action. Here we show that acid and base production at the electrodes precipitates local pH changes causing the rapid cell death that underlies macroscopic tumor necrosis at pH > 10.6 or < 4.8. The extent of cell death can be modulated by altering the local buffering capacity and antioxidant availability. These data demonstrate that electrolytic ablation is distinguished from other ablation strategies via its ability to induce cellular necrosis by directly altering the tumor microenvironment. These findings may enable further development of electrolytic ablation as a curative therapy for primary, early stage tumors.
format Online
Article
Text
id pubmed-6123816
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-61238162018-09-28 Electrolytic ablation enables cancer cell targeting through pH modulation Perkons, Nicholas R. Stein, Elliot J. Nwaezeapu, Chike Wildenberg, Joseph C. Saleh, Kamiel Itkin-Ofer, Roni Ackerman, Daniel Soulen, Michael C. Hunt, Stephen J. Nadolski, Gregory J. Gade, Terence P. Commun Biol Article Minimally invasive ablation strategies enable locoregional treatment of tumors. One such strategy, electrolytic ablation, functions through the local delivery of direct current without thermal effects, facilitating enhanced precision. However, the clinical application of electrolytic ablation is limited by an incompletely characterized mechanism of action. Here we show that acid and base production at the electrodes precipitates local pH changes causing the rapid cell death that underlies macroscopic tumor necrosis at pH > 10.6 or < 4.8. The extent of cell death can be modulated by altering the local buffering capacity and antioxidant availability. These data demonstrate that electrolytic ablation is distinguished from other ablation strategies via its ability to induce cellular necrosis by directly altering the tumor microenvironment. These findings may enable further development of electrolytic ablation as a curative therapy for primary, early stage tumors. Nature Publishing Group UK 2018-05-17 /pmc/articles/PMC6123816/ /pubmed/30271931 http://dx.doi.org/10.1038/s42003-018-0047-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Perkons, Nicholas R.
Stein, Elliot J.
Nwaezeapu, Chike
Wildenberg, Joseph C.
Saleh, Kamiel
Itkin-Ofer, Roni
Ackerman, Daniel
Soulen, Michael C.
Hunt, Stephen J.
Nadolski, Gregory J.
Gade, Terence P.
Electrolytic ablation enables cancer cell targeting through pH modulation
title Electrolytic ablation enables cancer cell targeting through pH modulation
title_full Electrolytic ablation enables cancer cell targeting through pH modulation
title_fullStr Electrolytic ablation enables cancer cell targeting through pH modulation
title_full_unstemmed Electrolytic ablation enables cancer cell targeting through pH modulation
title_short Electrolytic ablation enables cancer cell targeting through pH modulation
title_sort electrolytic ablation enables cancer cell targeting through ph modulation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123816/
https://www.ncbi.nlm.nih.gov/pubmed/30271931
http://dx.doi.org/10.1038/s42003-018-0047-1
work_keys_str_mv AT perkonsnicholasr electrolyticablationenablescancercelltargetingthroughphmodulation
AT steinelliotj electrolyticablationenablescancercelltargetingthroughphmodulation
AT nwaezeapuchike electrolyticablationenablescancercelltargetingthroughphmodulation
AT wildenbergjosephc electrolyticablationenablescancercelltargetingthroughphmodulation
AT salehkamiel electrolyticablationenablescancercelltargetingthroughphmodulation
AT itkinoferroni electrolyticablationenablescancercelltargetingthroughphmodulation
AT ackermandaniel electrolyticablationenablescancercelltargetingthroughphmodulation
AT soulenmichaelc electrolyticablationenablescancercelltargetingthroughphmodulation
AT huntstephenj electrolyticablationenablescancercelltargetingthroughphmodulation
AT nadolskigregoryj electrolyticablationenablescancercelltargetingthroughphmodulation
AT gadeterencep electrolyticablationenablescancercelltargetingthroughphmodulation